MedTrace Logo

System Accuracy of BGM GL22

NCT06146933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2023-11-27

No results posted yet for this study

Summary

This study assesses the system accuracy of a blood glucose monitoring system pursuant to ISO 15197

Conditions

Interventions

DIAGNOSTIC_TEST

Glucometer Test

blood glucose measurement using finger tip capillary blood using BGM

DIAGNOSTIC_TEST

Refernce Measurement

blood glucose measurement using finger tip capillary blood using reference method

Sponsors & Collaborators

  • Institut fur Diabetes Karlsburg GmbH

    lead OTHER

Principal Investigators

  • Kerstin Rebrin, PhD · Institut fur Diabetes Karlsburg GmbH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2023-11-22
Completion
2023-11-24

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06146933 on ClinicalTrials.gov